About this event
Cancer alone has been globally a major healthcare burden. Many cancers are detected at a late stage, screening and early diagnostics have been shown to make a difference in outcomes and save lives.
The global agenda to reduce the cancer death rate can be achieved by improving the existing screening/diagnostic solutions and bringing innovative solutions to the market, which are - more portable, simple to operate, has better precision to predict weak markers/signals, quicker, and cheaper.
Technology developers are working on various solutions, including artificial intelligence, algorithms, machine learning, image processing, advanced data analytics, and others to address the unmet needs in cancer diagnostics.
Join our webinar to know :
You can also view a related webinar held earlier by our Analysts on the topic - Combination Immunotherapy in Oncology: Harnessing the Power of Many
I am a Ph.D. in Pharmaceutical Sciences and have extensively been associated with clients looking for innovation, strategies, business, and sustainability in the field of Medical devices, diagnostics, and pharmaceuticals
I'm passionate about technology innovation and how it will shape the Future of the Life Sciences industry. I work with the client stakeholders from R&D, Innovation, Strategy, and BD&L to provide deep techno-commercial insights.
FutureBridge tracks and advises on the future of industries from a 1-to-25 year perspective.
We keep you ahead on the technology curve, propel your growth, Identify new opportunities,
We deliver on-demand, pro-active, strategic, tactical & executional insights on evolving technologies and markets.
Share this event